Suvretta Capital Management 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 90 US equity positions worth $4.0bn in its Q4 2025 13F filing. The largest position was ARQT at 8.7% of the reported book, followed by BENITEC BIOPHARMA INC and LEGN. Against the Q3 2025 filing, it opened 7 new positions, added to 24 and reduced 9 among the top 50 holdings.
What did Suvretta Capital Management own in Q4 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 8.7% | $347.4m | 11,964,000 | 14% | added |
| 2 | BENITEC BIOPHARMA INC | 3.9% | $155.6m | 11,548,351 | 17% | added | |
| 3 | LEGN LEGEND BIOTECH CORP | Healthcare | 3.6% | $143.7m | 6,608,629 | 73% | added |
| 4 | EYPT EYEPOINT INC | Healthcare | 3.6% | $143.0m | 7,827,685 | 26% | added |
| 5 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 3.1% | $123.7m | 5,188,858 | 41% | added |
| 6 | IMTX IMMATICS N.V | Healthcare | 2.9% | $117.5m | 11,190,129 | -7% | reduced |
| 7 | BHVN BIOHAVEN LTD | Healthcare | 2.9% | $116.1m | 10,286,937 | 83% | added |
| 8 | META META PLATFORMS INC | Communication Services | 2.8% | $111.6m | 169,069 | -1% | reduced |
| 9 | APELLIS PHARMACEUTICALS INC | 2.6% | $104.0m | 4,139,426 | 44% | added | |
| 10 | NVDA NVIDIA CORPORATION | Technology | 2.5% | $99.0m | 530,900 | 10% | added |
| 11 | KO COCA COLA CO | Consumer Defensive | 2.4% | $96.7m | 1,382,750 | -5% | reduced |
| 12 | GE GE AEROSPACE | Industrials | 2.4% | $95.6m | 310,262 | 0% | held |
| 13 | AMZN AMAZON COM INC | Consumer Cyclical | 2.3% | $93.7m | 406,146 | 86% | added |
| 14 | PALVELLA THERAPEUTICS INC NE | 2.3% | $93.4m | 892,400 | 9% | added | |
| 15 | KURA KURA ONCOLOGY INC | Healthcare | 2.2% | $89.1m | 8,575,422 | 6% | added |
| 16 | BAC BANK AMERICA CORP | Financial Services | 2.1% | $83.5m | 1,517,630 | 31% | added |
| 17 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.1% | $83.4m | 389,576 | -2% | reduced |
| 18 | HD HOME DEPOT INC | Consumer Cyclical | 2.1% | $82.9m | 240,861 | 22% | added |
| 19 | AVBP ARRIVENT BIOPHARMA INC | 2.1% | $82.6m | 4,106,035 | 11% | added | |
| 20 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 2.1% | $82.5m | 271,401 | -2% | reduced |
| 21 | SYY SYSCO CORP | Consumer Defensive | 2.0% | $79.9m | 1,083,790 | – | new |
| 22 | APO APOLLO GLOBAL MGMT INC | Financial Services | 2.0% | $78.6m | 542,890 | 26% | added |
| 23 | MSFT MICROSOFT CORP | Technology | 1.9% | $77.2m | 159,695 | 46% | added |
| 24 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.9% | $77.0m | 4,768,712 | 0% | held | |
| 25 | CMPX COMPASS THERAPEUTICS INC | 1.9% | $76.2m | 14,182,379 | 1% | added | |
| 26 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.8% | $74.2m | 6,561,111 | 22% | added |
| 27 | NOW SERVICENOW INC | Technology | 1.5% | $59.7m | 389,445 | 1670% | added |
| 28 | DHR DANAHER CORPORATION | Healthcare | 1.4% | $55.9m | 244,300 | -4% | reduced |
| 29 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.4% | $55.8m | 1,538,662 | -28% | reduced |
| 30 | ERAS ERASCA INC | Healthcare | 1.3% | $53.9m | 14,502,004 | 0% | held |
| 31 | CRM SALESFORCE INC | Technology | 1.3% | $53.0m | 199,900 | 60% | added |
| 32 | GLUE MONTE ROSA THERAPEUTICS INC | 1.3% | $52.7m | 3,360,000 | 0% | held | |
| 33 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 1.3% | $51.5m | 1,785,610 | – | new |
| 34 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.2% | $46.4m | 2,019,000 | 0% | held |
| 35 | ORCL ORACLE CORP | Technology | 1.1% | $44.1m | 226,318 | 0% | held |
| 36 | MGM MGM RESORTS INTERNATIONAL | Consumer Cyclical | 1.1% | $43.9m | 1,202,070 | – | new |
| 37 | COF CAPITAL ONE FINL CORP | Financial Services | 1.0% | $41.7m | 171,970 | -28% | reduced |
| 38 | TSLA TESLA INC | Consumer Cyclical | 1.0% | $41.0m | 91,252 | 0% | held |
| 39 | ADVISORSHARES TR | 1.0% | $40.9m | 8,669,600 | 21% | added | |
| 40 | UNH UNITEDHEALTH GROUP INC | Healthcare | 0.9% | $36.7m | 111,320 | 16% | added |
| 41 | FERG FERGUSON ENTERPRISES INC | Industrials | 0.9% | $35.4m | 159,190 | -48% | reduced |
| 42 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 0.8% | $33.7m | 353,561 | 0% | held |
| 43 | CTNM CONTINEUM THERAPEUTICS INC | 0.8% | $32.5m | 2,841,334 | 65% | added | |
| 44 | ZURA ZURA BIO LTD | Healthcare | 0.7% | $29.2m | 5,567,001 | 2% | added |
| 45 | UNIQURE NV | 0.7% | $29.1m | 1,216,734 | – | new | |
| 46 | PROK PROKIDNEY CORP | 0.7% | $27.6m | 12,341,266 | 0% | held | |
| 47 | COHR COHERENT CORP | Technology | 0.6% | $25.5m | 137,930 | – | new |
| 48 | CMG CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | 0.6% | $25.4m | 686,300 | – | new |
| 49 | AURA AURA BIOSCIENCES INC | 0.6% | $23.8m | 4,372,884 | 0% | held | |
| 50 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.6% | $23.6m | 2,662,227 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.